Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
13.02
P/B ratioShare price divided by book value per share.
1.59
P/S ratioMarket value divided by annual revenue.
2.47
PEG ratioP/E divided by the earnings growth rate.
2.68
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
7.42
EV / RevenueEnterprise value against annual revenue.
1.87
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
7.68%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
49.20%
Operating marginRevenue left after operating costs.
21.35%
Net marginRevenue left after every cost, including tax and interest.
17.86%
Return on equityProfit as a percentage of shareholders’ equity.
12.67%
Return on assetsProfit as a percentage of total assets.
6.10%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
2.48
Quick ratioThe same, excluding inventory.
1.95
Debt to equityTotal borrowings against shareholders’ equity.
0.03
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$0.89
Book value per shareShareholders’ equity divided by shares outstanding.
$7.31
Shares outstandingShares currently issued.
861,029,140
Market capitalisationShare price times shares outstanding.
$9.98B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
3,732
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
3.06%
Payout ratioShare of profit paid out as dividends.
What is Zhejiang Jingxin Pharmaceutical Co., Ltd.'s P/E ratio?
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) trades on a price-to-earnings ratio of 13.02.
What is Zhejiang Jingxin Pharmaceutical Co., Ltd.'s return on equity?
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) reports a return on equity of 12.67%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Zhejiang Jingxin Pharmaceutical Co., Ltd. carry?
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has a debt-to-equity ratio of 0.03, which compares total borrowings with shareholders' equity.
What is Zhejiang Jingxin Pharmaceutical Co., Ltd.'s profit margin?
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) keeps 17.86% of revenue as net profit after every cost, including tax and interest.